The US Embassy in New Delhi has revoked and denied visas to several Indian company executives, as well as members of their families, after identifying their alleged involvement in the trafficking of precursor chemicals used in the production of fentanyl.
According to US officials, the sanctions are part of a
broader effort to stem the international flow of substances used in the
manufacture of this synthetic opioid, responsible for a public health crisis in
the United States that has left tens of thousands of overdose deaths each year.
Fentanyl precursors, which in many cases are produced
legally in chemical laboratories, are diverted to criminal networks that use
them to manufacture illicit drugs. Washington has intensified diplomatic
pressure on countries such as India and China, considered key sources of these
compounds, to strengthen oversight and control of their exports.
US authorities emphasized that the measure against the
executives and their families seeks to send a clear message of "zero
tolerance" toward corporate collaboration with drug trafficking, even when
it involves actors operating under apparent legality. For its part, the Indian
government has so far not issued an official response to the embassy's
decisions.
Post a Comment
We want to know your comments and concerns. Remember: Respect distinguishes us, education makes us different...